|  Help  |  About  |  Contact Us

Publication : Identification of XAF1 as an endogenous AKT inhibitor.

First Author  Chen M Year  2023
Journal  Cell Rep Volume  42
Issue  7 Pages  112690
PubMed ID  37384528 Mgi Jnum  J:338549
Mgi Id  MGI:7513766 Doi  10.1016/j.celrep.2023.112690
Citation  Chen M, et al. (2023) Identification of XAF1 as an endogenous AKT inhibitor. Cell Rep 42(7):112690
abstractText  AKT kinase is a key regulator in cell metabolism and survival, and its activation is strictly modulated. Herein, we identify XAF1 (XIAP-associated factor) as a direct interacting protein of AKT1, which strongly binds the N-terminal region of AKT1 to block its K63-linked poly-ubiquitination and subsequent activation. Consistently, Xaf1 knockout causes AKT activation in mouse muscle and fat tissues and reduces body weight gain and insulin resistance induced by high-fat diet. Pathologically, XAF1 expression is low and anti-correlated with the phosphorylated p-T308-AKT signal in prostate cancer samples, and Xaf1 knockout stimulates the p-T308-AKT signal to accelerate spontaneous prostate tumorigenesis in mice with Pten heterozygous loss. And ectopic expression of wild-type XAF1, but not the cancer-derived P277L mutant, inhibits orthotopic tumorigenesis. We further identify Forkhead box O 1 (FOXO1) as a transcriptional regulator of XAF1, thus forming a negative feedback loop between AKT1 and XAF1. These results reveal an important intrinsic regulatory mechanism of AKT signaling.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

5 Bio Entities

0 Expression